Pipeline | Target | Preclinical Research | Preclinical Development | Phase 1/2 | |
---|---|---|---|---|---|
Cancer Vaccine |
TB-CV-01 | Personalized Neoantigen |
|||
TB-CV-02 | Shared Neoantigen |
||||
Targeted Thearpy |
TB-ADC-01 | MUC13 | |||
TB-ADC-02 | CEACAM5 | ||||
TB-SM-01 | MAPK3 |